# Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects

> **NCT02145130** · PHASE1 · COMPLETED · sponsor: **University of Zurich** · enrollment: 12 (actual)

## Conditions studied

- Burn Injury
- Soft Tissue Injury
- Skin Necrosis
- Scars
- Congenital Giant Nevus
- Skin Tumors

## Interventions

- **BIOLOGICAL:** denovoDerm
- **BIOLOGICAL:** denovoSkin

## Key facts

- **NCT ID:** NCT02145130
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145130, "Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02145130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*